TRxADE HEALTH Inc (MEDS) - Enterprise Value to EBITDA Ratio

Public company logo of TRxADE (MEDS)

The visual representation of EV/EBITDA multiples, which stands at 0.00, demonstrates the efficiency of TRxADE HEALTH (MEDS) in deploying digital services for pharmacy retail through strategic alliances with suppliers. However, a shift in commercial strategy has triggered financial volatility and a shortage of stable cash flows. Synergistic groups of programmers and pharmacy experts, aiming to transform drug logistics, are currently driving the platform's development.

TRxADE HEALTH Inc - MEDS EV/EBITDA Multiple (period 11/23/2025 - 11/12/2026)
Product sample of TRxADE HEALTH Inc

Stress-testing assets requires analyzing business value relative to its ability to generate cash flow. For TRxADE HEALTH, Inc. (MEDS), which monetizes transactions within a cloud-based B2B pharmacy marketplace, operating profit efficiency is critical. By analyzing fluctuations in the EV/EBITDA multiple, an investor compares total capitalization, including debt, against actual earnings to determine whether the company is overvalued or undervalued.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|Business Value to Operating Income Before Depreciation DOCS|HQY: Enterprise Value to EBITDA Ratio|WAY (waystar.com) - Enterprise Value to Operating Income Before Depreciation|CRVL: EV/EBITDA Multiple|Privia Health Group, Inc. (PRVA) - EV/EBITDA Multiple|HURN (Huron Consulting) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CERT (Certara Software)|EV/EBITDA Multiple OMCL|GDRX - Company Value to EBITDA|Schrödinger - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation PHR|Omada Health Corp - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation EVH (Evolent Corp)|HSTM: EV/EBITDA Multiple|Company Value to EBITDA definitivehc.com (DH)|CCSI (Consensus Cloud Solutions, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple agilon health, inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Absci Corp. (ABSI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SY (So-Young Corp)|National Research - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio SPOK (spok.com)|OptimizeRx - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation TBRG (TruBridge Inc)|SLP (Simulations Plus Corp) - Enterprise Value to EBITDA Ratio|SOPHiA GENETICS - Business Value to Operating Income Before Depreciation|HCAT (Health Catalyst, Inc.) - EV/EBITDA Multiple|CareCloud Corp (CCLD) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Research Solutions, Inc. (RSSS)|dlhcorp.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ONMD (OneMedNet)|SCNX - Enterprise Value to EBITDA Ratio|HCTI: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio iSpecimen Inc. ISPC|bullfrogai.com (BFRG) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio SCWorx Corp|MSPR (LifeWallet) - EV/EBITDA Multiple|Company Value to EBITDA iCoreConnect Corp ICCT|EV/EBITDA Multiple ORGS|r1rcm.com - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sharecare SHCR|Total Company Value to Operating Income Before Depreciation Ratio Streamline Health Solutions, Inc. (STRM)|Syra Health Corporation - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Apollo Medical Holdings AMEH|MODN (Model N, Inc.) - Enterprise Value to EBITDA Ratio|NXGN: Enterprise Value to Operating Income Before Depreciation Ratio